Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-12-17

FDA Approved: FLUVOXAMINE MALEATE — Supplemental Application (Apotex Corp)

View source ↗

Summary

The FDA approved a supplemental application for fluvoxamine maleate from Apotex Corp, resulting in approval of a generic version.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluvoxamine Maleate (Fluvoxamine maleate)

Snippet

SUPPL AP for FLUVOXAMINE MALEATE (FLUVOXAMINE MALEATE)